1177638

Joel Vandersluis, M.D. — FEI 3023194189

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 12, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dayton, OH (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance